ImmuPharma (LON:IMM) Stock Price Up 27.6% – What’s Next?
by Sarita Garza · The Markets DailyImmuPharma plc (LON:IMM – Get Free Report) shares were up 27.6% during trading on Friday . The stock traded as high as GBX 3.60 ($0.04) and last traded at GBX 3.35 ($0.04). Approximately 8,992,934 shares were traded during trading, a decline of 61% from the average daily volume of 23,308,711 shares. The stock had previously closed at GBX 2.63 ($0.03).
ImmuPharma Stock Up 27.6 %
The firm has a 50 day simple moving average of GBX 1.56 and a two-hundred day simple moving average of GBX 1.68. The stock has a market capitalization of £13.95 million, a P/E ratio of -335.00 and a beta of 1.53.
About ImmuPharma
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
Featured Stories
- Five stocks we like better than ImmuPharma
- There Are Different Types of Stock To Invest In
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- Using the MarketBeat Stock Split Calculator
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- Business Services Stocks Investing
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside